跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Selective Killing: How Chemotherapy Harms Cancer Cells More Than Normal Cells

1The Selectivity Problem: Why Preferential Killing Is Possible but Imperfect2Proliferation as the Primary Vulnerability: Cell-Cycle Dependence3Antimetabolites and the S-Phase Trap4Microtubule Poisons and Mitotic Arrest5DNA-Damaging Agents: Alkylators, Crosslinkers, and Topoisomerase Poisons6The DNA-Damage Response and the Decision to Die7Why Selectivity Fails: Normal-Tissue Toxicity and the Limits of the Window8Resistance: How Tumors Escape and What It Reveals About Selectivity9Widening the Window: Clinical Strategies That Exploit Selectivity
Antimetabolites and the S-Phase Trap

Thymineless Death: Why an Imbalanced Pool Kills S-Phase Cells

2 / 3
The damage here is not just a shortage of thymidine — it is the imbalance. When dTTP falls but dUTP stays high, DNA polymerase misincorporates uracil, repair enzymes cut it out, and the repeated cycles of misincorporation and repair fragment the genome. Replication forks stall and can collapse into double-strand breaks. Because this happens during replication, cells in G1, G2, M, or G0 are largely spared. That is the S-phase trap. Leucovorin rescue reverses the block in normal tissues by supplying reduced folate downstream of methotrexate, but timing matters — too much rescue and the tumor is protected too.
0:00 / 0:00

Inhibiting thymidylate synthase lowers dTTP without lowering the other deoxynucleotides. The imbalance, not just the shortage, is what damages DNA: dUTP is misincorporated, uracil-DNA glycosylase excises it, and the resulting abasic sites and strand breaks accumulate. Replication forks stall at these lesions and can collapse into double-strand breaks, driving the cell toward apoptosis.

The lethal consequence depends on replication. Cells in G1, G2, M, or G0 are not actively copying DNA, so they are largely spared during the exposure window. A tumor with a high growth fraction continuously feeds cells into S phase, which is why phase-specific antimetabolites require prolonged or repeated exposure to catch successive cohorts.

Leucovorin rescue

Leucovorin is a reduced folate that bypasses the methotrexate block on dihydrofolate reductase and restores thymidylate synthesis. After a high-dose methotrexate infusion, it is given to rescue normal tissues, which have accumulated less drug than the tumor. The tumor remains blocked long enough to die. Timing is critical: rescue given too early or too generously can protect the tumor as well.

Antimetabolite selectivity is not absolute; it is a consequence of the S-phase restriction of the lethal lesion. The therapeutic window depends on the tumor having a higher fraction of cycling cells than the dose-limiting normal tissues, and on the drug remaining present long enough to catch those cells in S phase.

参考资料

  1. [1]Leucovorin — StatPearls, NCBI Bookshelfncbi.nlm.nih.gov
上一页2 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion